Brussels, Belgium

Eric Jnoff


 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ecaussinnes, BE (2017)
  • Brussels, BE (2018 - 2019)

Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eric Jnoff: Innovator in Pharmaceutical Chemistry

Introduction

Eric Jnoff is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on tetrahydroisoquinoline derivatives. With a total of 4 patents to his name, Jnoff's innovations are paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Jnoff has developed tetrahydroisoquinoline derivatives that serve as Positive Allosteric Modulators of D1 receptors. These compounds are beneficial as pharmaceutical agents for treating diseases where D1 receptors play a crucial role. His work in this area demonstrates a commitment to enhancing therapeutic options for various medical conditions.

Career Highlights

Throughout his career, Eric Jnoff has worked with prominent companies such as UCB Biopharma and UCB Pharma. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Jnoff has collaborated with talented individuals in his field, including Ali Ates and Anne Valade. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

Eric Jnoff's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…